BHL-89

98070109, human lymph (axillary), Lymphoblastoid

• UNSPSC-Code: 41106514

Eigenschaften

• product name: BHL-89, 98070109
• Biologische Quelle: human lymph (axillary)
• Wachstumsmodus: Suspension
• Karyotyp: Hyperdiploid, modal no. 47, chromosome 1 trisomy, 15 monosomy, +14q+
• Morphologie: Lymphoblastoid
• Produkte: Not specified
• Rezeptoren: sIgM,CD22,BB1,HLA-ABC,GnRH
• Methode(n): cell culture | mammalian: suitable
• Relevante Krankheit(en): cancer
• Versandbedingung: dry ice
• Lagertemp.: −196°C

Beschreibung

Ursprung der Zelllinie

Human B-type EBNA negative lymphoma

Beschreibung der Zelllinie

The cell line BHL-89 was established from a 56 year old female patient with chronic lymphoid leukaemia (CLL). The B-cell type cells were shown to express CD9, CD22, CD71,HLA-ABC, BB1, GnRH and surface IgM. Cloning efficiency in soft agar was found to be between 20-60% and population doubling time was 48 hours. BHL-89 cells are Epstein-Barr nuclear antigen (EBNA) negative. They have been shown to be tumourigenic in immunosuppressed mice, sensitive to dibromodulcitol and resistant to the phorbol ester TPA. The cell line was found to be positive for BCL-2 protein and produces small amounts of interferon. Lymphoblastoid cells and floating aggregates. The cell line has been eradicated from mycoplasma at ECACC.

Anwendung

B lymphoma studies, cancer treatments

Nährmedium

RPMI1640 + 2mM Glutamine + 15% Foetal Bovine Serum (FBS).

Subkultur-Routine

Maintain cultures between 1-5 x 100,000 cells/ml;5% CO₂; 37°C

Sonstige Hinweise

Additional freight & handling charges may be applicable for Asia-Pacific shipments. Please check with your local Customer Service representative for more information.